While gallium tracers have a higher urinary excretion, potentially limiting the ability to assess the prostatic compartment or surrounding pelvic lymph nodes, a delay in urinary excretion with fluorinated tracers (most notably the [18F]PSMA-1007) has been hailed as a distinct advantage [28]; however, a recently published paper demonstrated that within the first 10 minutes after injection of [68Ga]Ga-PSMA-11, the local recurrence of PCa showed significant accumulation, while the bladder did not yet show activity, thus allowing better delineation of the recurrence [29]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.